07/10/2025 00:00
Biocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug Development

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a global licensing agreement with BeOne Medicines Ltd., a global oncology company, for multiple fully human antibodies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250709204455/en/ Prior...

06/04/2025 03:00
Ant International Pushes AI Strategy with AI Platform for Fintechs

Ant International, a leading global digital payment, and financial technology provider, today unveils its AI strategy with the launch of Alipay+ GenAI Cockpit, an AI-as-a-Service (AIaaS) platform that empowers fintech companies and super apps to build AI-agentic and ultimately AI-native financial services with enhanced efficiency, security, and flexibility. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2...

06/09/2025 00:00
Samsung Bioepis Enters into a Strategic Partnership with NIPRO for Commercialization of Multiple Biosimilars in Japan

Samsung Bioepis Co., Ltd. (“Samsung Bioepis”) announced today that the company has entered into a license, development and commercialization agreement with NIPRO Corporation (“NIPRO”) for multiple biosimilar candidates including SB17, ustekinumab biosimilar candidate, in Japan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250608582351/en/Samsung Bioepis (President and CEO: Kyung-Ah Kim) has entered into a license, development and ...

Medialab

Medialab

Research & Development

AFP Medialab is a small multi-disciplinary team aimed to boost innovation at AFP. It participates in several R&D projects with French or European funding. AFP Medialab is the main developer of the InVID-WeVerify browser extension, one of the main toolboxes to debunk disinformation. This toolbox has attracted more than 90,000 weekly active users from 224 countries at the beginning of 2023.

 

'What would you have us do?': the plastic credits problem

This investigation by AFP and SourceMaterial reveals that the plastic credits system relies heavily on cement plants, where large quantities of waste are incinerated, making this industry more polluting than aviation.

This investigation by AFP and SourceMaterial reveals that the plastic credits system relies heavily on cement plants, where large quantities of waste are incinerated, making this industry more polluting than aviation.

AFP successfully tests a new technology to verify the authenticity of its photos during the US elections

With the rise of generative AI and the growing use of synthetic images, Agence France-Presse (AFP) has successfully tested a “proof of concept” to certify the authenticity of its photos, ensuring they can be verified wherever they appear online. The Agency now plans to develop this technology further in collaboration with camera manufacturers, editing software developers, and news distributors, working towards a shared industry standard that protects the integrity of photojournalism.

With the rise of generative AI and the growing use of synthetic images, Agence France-Presse (AFP) has successfully tested a “proof of concept” to certify the authenticity of its photos, ensuring they can be verified wherever they appear online. The Agency now plans to develop this technology further in collaboration with camera manufacturers, editing software developers, and news distributors, working towards a shared industry standard that protects the integrity of photojournalism.
06/30/2025 12:00
Takeda Announces U.S. FDA Approval of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content1

Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved GAMMAGARD LIQUID ERC [immune globulin infusion (human)] with less than or equal to 2 µg/mL IgA in a 10% solution, the only ready-to-use liquid immunoglobulin (IG) therapy with low immunoglobulin A (IgA) content, as replacement therapy for people two years of age and older with primary immunodeficiency (PI). As a ready-to-use liquid, GAMMAGARD LIQUID ERC may help ease the administration burde...

AFP photographer Mahmud Hams wins top prize for Gaza coverage

Palestinian AFP photographer Mahmud Hams has won the prestigious Visa d'Or News prize for his coverage of the conflict in Gaza, the Visa pour l'image Association announced Saturday.

Palestinian AFP photographer Mahmud Hams has won the prestigious Visa d'Or News prize for his coverage of the conflict in Gaza, the Visa pour l'image Association announced Saturday.
07/10/2025 02:00
Murata Begins World’s First Mass Production of 47μF Multilayer Ceramic Capacitor in 0402-inch Size

Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has begun the world’s first mass production of the 0402-inch size (1.0 × 0.5 mm) multilayer ceramic capacitors (MLCC) with a capacitance of 47μF*. The new product line, available in two variants with different temperature characteristics, is designed to advance MLCC miniaturization and enhance customer system performance. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2...

05/30/2025 09:17
Indian Educationist Dr. Achyuta Samanta Recognised With Research Institute in His Name at CUNY, USA

In a noteworthy development underscoring growing academic collaboration between India and the United States, the City University of New York (CUNY) has launched a dedicated research platform—the Achyuta Samanta India Initiative of the CUNY CREST Institute (ASIICCI). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250529012005/en/Dr. Milton Santiago, President of Bronx Community College, and Dr. Achyuta Samanta, Founder of KIIT & ...